Transaction DateRecipientSharesTypePriceValue
20th November 2020David F Burgstahler4,936,926Other acquisition or disposition$0.00
20th November 2020Sriram Venkataraman4,936,926Other acquisition or disposition$0.00
20th November 2020Capital Partners Iii Gp, L.P. Avista4,936,926Other acquisition or disposition$0.00
1st October 2020Brian A Markison2,277Grant/award etc.$0.00
10th August 2020Brian A Markison1,354Grant/award etc.$0.00
21st May 2020Fred G Weiss17,778Payment by withholding$4.60$81,778.80
21st May 2020Gregory L Cowan11,112Payment by withholding$4.60$51,115.20
20th May 2020Brian A Markison249,787Grant/award etc.$0.00
20th May 2020Fred G Weiss38,716Grant/award etc.$0.00
20th May 2020Gregory L Cowan38,716Grant/award etc.$0.00
Osmotica Pharmaceuticals Plc
Osmotica Pharmaceuticals Plc logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

Ticker: OSMT
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1739426
Employees: 379
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags